NCT05403346View on ClinicalTrials.gov

Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)

TerminatedOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

October 31, 2022

Conditions

SARS-CoV-2Covid19

Interventions

DEVICE

CoviDx™ Covid-19 Antigen Self-Test

All patients will self-collect a mid-turbinate nasal swab for CoviDx™ Covid-19 Antigen self-testing

Trial Locations (1)

33613

PAS Research, Tampa

Sponsors

Lead Sponsor

Lumos Diagnostics

All Listed Sponsors

collaborator

Rapid Pathogen Screening

INDUSTRY

lead

Lumos Diagnostics

INDUSTRY

NCT05403346 - Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™) | Biotech Hunter | Biotech Hunter